Arkema to increase its global Pebax elastomers production capacity by 25%

To support its customers’ strong growth, in particular in the sports and consumer goods markets, Arkema will increase its global manufacturing capacity for Pebax® elastomers by approximately 25% through an investment at its Serquigny plant in France.

Arkema announces a 25% increase in its global Pebax® elastomer production capacity by investing in Serquigny in France. This investment will notably enable increased production of the biocircular Pebax® Rnew® and traditional Pebax® ranges. This new capacity will produce a variety of highly specialized grades to meet growing demand in numerous demanding applications thanks to the lightweight, flexibility and excellent energy return of these materials. These properties are particularly appreciated in sports equipment, such as soles for running shoes, ski boots or technical textile, in consumer goods such as smartphones and flexible screens, as well as in other markets such as medical equipment.
Derived from renewable castor seeds, Pebax® Rnew® advanced biocircular materials offer a sustainable solution to our customers who are increasingly driven by sustainability and social responsibility. Compared to other elastomers on the market, these materials have a carbon footprint that is up to 50% lower and can be fully recycled. In addition, this investment, which is scheduled to come on stream mid2023, will lower the water consumption of the site by 25% thanks to process optimization.

We are very excited to commit to an expansion in our Pebax® elastomers capacity” said Erwoan Pezron, Senior VicePresident of Arkema’s High Performance Polymers Business Line. “The Serquigny plant has a long proven legacy in the production of these advanced materials, and we are delighted to add this new capacity to support our customers’ growing demand for highperformance sustainable materials. We will also continue to produce many of these materials at our Birdsboro plant in Pennsylvania.